Journal of Radioanalytical and Nuclear Chemistry

, Volume 283, Issue 2, pp 503–506 | Cite as

Could be radiolabeled flavonoid used to evaluate infection?

  • F. Yurt LambrechtEmail author
  • O. Yilmaz
  • E. Bayrak
  • G. Kocagozoglu
  • K. Durkan


The aim of this study was to determine whether [131I]apigenin is a powerful and discrimination infection from inflammation for scintigraphic imaging. The study was carried out in inflamed rats with Staphylococcus aureus (S. aureus) and sterile inflamed rats with turpentine oil. Biodistribution study of [131I]apigenin was performed in the rats. Apigenin was labeled with 131I by iodogen method. Obtained [131I]apigenin with high yield (98%) was injected i.v. to both group rats. The results were expressed as the percent uptake of injected dose per gram of organ (%ID/g), the bacterial infected and sterile inflamed muscles. Binding of [131I]apigenin to the infected thigh muscle (target muscle = T) and normal thigh muscle (non-target muscle = NT) ratio (T/NT = 4.51 at 15 min) was higher than binding to bacterial inflamed muscle (T/NT = 2.25 at 15 min) of rats. [131I]apigenin showed good localization in both inflamed tissues. This uptake in the sterile inflamed tissue is higher than bacterial infected tissue. [131I]apigenin might be useful for imaging of inflamed tissues. However, it is not discriminate sterile inflamed tissue from bacterial infected tissue.


Apigenin Inflamed rat S. aureus Imaging [131I]apigenin 


  1. 1.
    Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doself AI (2007) Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kB through the suppression of p65 phosphorylation. J Immun 179:7121–7127Google Scholar
  2. 2.
    Panes J, Gerritsen ME, Anderson DC, Miyasaka M, Granger DN (1996) Apigenin inhibits tumor necrosis factor-induced intercellular adhesion molecule-1 upregulation in vivo. Microcirculation 3:279–286CrossRefGoogle Scholar
  3. 3.
    Liang YC, Huang YT, Tsai SH, Lin Shiau SY, Chen CF, Lin JK (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in Mouse macrophages. Carcinogonesis 20:1945–1952CrossRefGoogle Scholar
  4. 4.
    Cushnie TPT, Hamilton VES, Lamb AJ (2003) Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports. Microbial Res 158:281–289CrossRefGoogle Scholar
  5. 5.
    Manthey JA (2000) Biological properties of flavonoids pertaining to inflammation. Microcirculation 7:29–34CrossRefGoogle Scholar
  6. 6.
    Jeong KW, Lee JY, Kim Y (2007) Homology modeling and docking study of β-ketoacyl acyl carrier protein synthase III from Enterococcus faecalis. Bull Korean Chem Soc 28:1335–1340CrossRefGoogle Scholar
  7. 7.
    Gradolatto A, Canivenc-Lavier MC, Basly JP, Siess MH, Teyssier C (2004) Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver. Am Soc Pharm Exp Therp 32:58–65Google Scholar
  8. 8.
    Patel D, Shukla S, Gupta S (2007) Apigenin and cancer chemoprevention: progress, potential and promise. Int J Oncol 30:233–245Google Scholar
  9. 9.
    Wen X, Walle T (2006) Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Am Soc Pharm Exp Therp 34:1786–1792Google Scholar
  10. 10.
    Gradolatto A, Basly JP, Berges R, Teyssier C, Chagnon MC, Siess MH, Canivenc-Lavier MC (2005) Pharmacokinetics and metabolism of apigenin in female and male rats after a signal oral administration. Am Soc Pharm Exp Therp 33:49–54Google Scholar
  11. 11.
    Tim Cushnie TP, Hamilton VES, Lamb AJ (2003) Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reported. Microbiol Res 158:281–289CrossRefGoogle Scholar
  12. 12.
    Das SS, Hall AV, Wareham DDW, Britton KE (2002) Infection imaging with radiopharmaceuticals in the 21st century. Brazil Arch Biol Technol 45:25–37Google Scholar
  13. 13.
    El-Ghany EA, Amine AM, El-Kolaly MT, El-Sayed AS, Abdel-Gelil F (2005) Radiochemical and biological characteristics of radioactive iodine labeled indomethacin for imaging of inflammation. J Radioanal Nucl Chem 266:117–124CrossRefGoogle Scholar
  14. 14.
    Lupetti A, Welling MM, Paulwels EKJ, Nibbering PH (2003) Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 3:223–229CrossRefGoogle Scholar
  15. 15.
    Lambrecht FY, Yilmaz O, Unak P, Seyitoglu B, Durkan K, Yolcular S, Baskan H (2008) Imaging of bacterial infection with 99mTc-labeled HBD-1. J Radioanal Nucl Chem 277:555–559CrossRefGoogle Scholar
  16. 16.
    Seyitoglu B, Yurt Lambrecht F, Durkan K (2009) Labeling of apigenin with 131I and bioactivity of 131I-apigenin in male and female rats. J Radioanal Nucl Chem 279:867–873CrossRefGoogle Scholar
  17. 17.
    Roohi S, Mushtaq A, Malik SA (2005) Synthesis and biodistribution of [99mTc]Vancomycin in a model of bacterial infection. Radiochim Acta 93:415–418CrossRefGoogle Scholar
  18. 18.
    Roohi S, Mushtaq A, Malik SA, Jehangir M, Malik SA (2006) Synthesis, quality control and biodistribution of 99mTc-Kanamycin. J Radioanal Nucl Chem 267:561–566CrossRefGoogle Scholar
  19. 19.
    Tsopelas C, Penglis S, Ruszkiewicz A, Bartholomeusz FDL (2003) 99mTc-Alafosfalin: an antibiotic peptide infection imaging agent. Nucl Med Biol 30:169–175CrossRefGoogle Scholar
  20. 20.
    Yurt Lambrecht F, Yilmaz O, Unak P, Seyitoglu B, Durkan K, Baskan H (2008) Evaluation of 99mTc-Cefuroxime axetil for imaging of inflammation. J Radioanal Nucl Chem 277(2):491–494Google Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2009

Authors and Affiliations

  • F. Yurt Lambrecht
    • 1
    Email author
  • O. Yilmaz
    • 2
  • E. Bayrak
    • 1
  • G. Kocagozoglu
    • 1
  • K. Durkan
    • 1
  1. 1.Department of Nuclear ApplicationsInstitute of Nuclear Science, Ege UniversityIzmirTurkey
  2. 2.Department of Animal Research CenterDokuz Eylul UniversityIzmirTurkey

Personalised recommendations